Status:
UNKNOWN
Clinical Observation on the Treatment of Motor and Sensory Dysfunction After Stroke With Ruyizhenbao Pill
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Conditions:
Post-stroke Patients With Motor and Sensory Dysfunction
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
Many years of clinical practice experience has found that Ruyi treasure pill can be used to treat nerve meridian injury caused by cerebrovascular disease, but in the end, the clinical efficacy is stil...
Eligibility Criteria
Inclusion
- Compliance with stroke diagnostic criteria;
- The course of the disease is 15 days to 6 months;
- People who are conscious and have no severe cognitive impairment, and those who cooperate with examination and treatment;
- Age 20 to 80 years old;
- Sign an informed consent and participate voluntarily in the study.
Exclusion
- Diseases such as brain tumours, traumatic brain injury, brain parasitic diseases and metabolic disorders have been confirmed by examination;
- Combining patients with severe heart, liver, kidney, hematopoietic and endocrine systems, gastrointestinal diseases, etc.;
- Those who are not aware or concoced due to more severe cognitive impairment and complete aphasia;
- People who are allergic to the drug or are allergic to multiple medications.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04029701
Start Date
January 1 2017
End Date
December 31 2019
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China, 510006